Literature DB >> 25240710

Determination of oxidative stress and effect of erdosteine on rhinitis medicamentosa in a rat model.

Recep Dokuyucu1, Cengiz Cevik2, Gul Soylu Ozler2, Tumay Ozgur3, Cengiz Arli2, Fatih Sefil4, Zafer Yonden5.   

Abstract

We aimed to determine the presence of oxidative stress in rhinitis medicamentosa (RM) and to evaluate the effect of erdosteine (ED) on mucosal changes in a rat model. Twenty-four male rats were used in this experimental study. Three groups were created. Group 1 (n=8) was the control group. Two puffs of 0.05% oxymetazolin were sprayed into the nasal cavities of the remaining rats (n=16) three times daily for eight weeks. One of these 16 rats was scarified at the end of the eight weeks and examined to confirm the presence of RM. Seven of the remaining 16 rats were killed, and venous blood samples were taken (Group 2). Group 3 (n=8) received 10mg/kg of an ED suspension orally for seven days. All rats were put on formalin for light microscopy. The total antioxidant status (TAS) was similar in all groups (p=0.073). The total oxidative status (TOS) of the RM group was significantly higher than that of the control group and RM+ED group (Group 3) (p=0.003 and p=0.011, respectively). The pathological recovery of the nasal mucosa of the rats was similar in the RM+ED and control groups. The TOS was high in this RM rat model, and oxidative stress was associated with RM. ED significantly ameliorated nasal mucosal changes induced by RM, suggesting that oxidative stress may play an important role in the pathophysiology of this condition.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Erdostein; Experimental study; Rhinitis medicamentosa; Total antioxidant status; Total oxidative status

Mesh:

Substances:

Year:  2014        PMID: 25240710     DOI: 10.1016/j.ejphar.2014.09.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Systemic side effects of locally used oxymetazoline.

Authors:  Recep Dokuyucu; Hasan Gokce; Mustafa Sahan; Fatih Sefil; Zeynel Abidin Tas; Okan Tutuk; Atakan Ozturk; Cemil Tumer; Cengiz Cevik
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.

Authors:  Behram Cam; Murat Sari; Ahmet Midi; Ozgül Gergin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-29       Impact factor: 2.503

3.  The importance of vascular epithelial growth factor (VEGF) and inducible nitric oxide synthase (INOS) in rhinitis medicamentosa pathogenesis: An experimental rat model study.

Authors:  Alev Cumbul; Fuat Bulut
Journal:  Histol Histopathol       Date:  2021-11-29       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.